Asensus Surgical, Inc. ASXC
Set alert
0.35 0.00 0.00%
At close · Aug 21
0.346 Day range 0.3495
52-week range unavailable
- Open
- 0.346
- Prev close
- 0.3479
- Mkt cap
- 94.92M
- Vol
- 3.94M
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.346
- High
- 0.3495
- Forward P/E
- -2.68
- Beta
- 1.38
- Short ratio
- 7.11
- Inst. own
- 18.27%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 13, 2024
- 50-d avg
- 0.328538
- 200-d avg
- 0.289417
- 1y target
- 0.35
MAX chart
Events in this range
- Jan 9, 2023Rating: HC Wainwright & Co. · — → Buy
- Feb 21, 2023Rating: HC Wainwright & Co. · — → Buy
- Mar 5, 2023Rating: HC Wainwright & Co. · — → Buy
- May 11, 2023Earnings: —; estimate -0.07; surprise —%
- May 11, 2023Rating: HC Wainwright & Co. · Buy → Buy
- Aug 10, 2023Earnings: —; estimate -0.08; surprise —%
- Aug 10, 2023Rating: HC Wainwright & Co. · Buy → Buy
- Aug 21, 2023Rating: Cantor Fitzgerald · Overweight → Overweight
- Nov 14, 2023Earnings: —; estimate -0.07; surprise —%
- Mar 21, 2024Earnings: —; estimate -0.05; surprise —%
- May 14, 2024Earnings: —; estimate -0.05; surprise —%
- Aug 13, 2024Earnings: —; estimate -0.05; surprise —%
Signals (36)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Aug 21, 2024 | 2 years ago |
| SMA: Bearish | Aug 5, 2024 | 2 years ago |
| SMA: Bullish | Jun 10, 2024 | 2 years ago |
| SMA: Bullish | Jun 10, 2024 | 2 years ago |
| MACD: Buy Signal | Jun 10, 2024 | 2 years ago |
| MACD: Sell Signal | Jun 3, 2024 | 2 years ago |
| SMA: Bearish | May 17, 2024 | 2 years ago |
| SMA: Bullish | May 10, 2024 | 2 years ago |
| SMA: Bearish | Mar 28, 2024 | 2 years ago |
| SMA: Bearish | Feb 22, 2024 | 2 years ago |
| SMA: Bullish | Feb 15, 2024 | 2 years ago |
| SMA: Bullish | Feb 15, 2024 | 2 years ago |
| SMA: Bearish | Jan 25, 2024 | 2 years ago |
| SMA: Bearish | Jan 18, 2024 | 2 years ago |
| SMA: Bullish | Jan 11, 2024 | 2 years ago |
| SMA: Bullish | Nov 30, 2023 | 2 years ago |
| MACD: Buy Signal | Nov 22, 2023 | 2 years ago |
| SMA: Bearish | Jul 25, 2023 | 3 years ago |
| SMA: Bullish | Jul 18, 2023 | 3 years ago |
| SMA: Bearish | May 23, 2023 | 3 years ago |
| MACD: Sell Signal | May 2, 2023 | 3 years ago |
| SMA: Bearish | Apr 25, 2023 | 3 years ago |
| SMA: Bullish | Apr 18, 2023 | 3 years ago |
| SMA: Bearish | Mar 14, 2023 | 3 years ago |
| SMA: Bullish | Jan 10, 2023 | 3 years ago |
| SMA: Bullish | Jan 10, 2023 | 3 years ago |
| MACD: Buy Signal | Jan 10, 2023 | 3 years ago |
| MACD: Sell Signal | Dec 27, 2022 | 3 years ago |
| SMA: Bearish | Nov 22, 2022 | 3 years ago |
| SMA: Bearish | Nov 22, 2022 | 3 years ago |
| SMA: Bullish | Nov 15, 2022 | 3 years ago |
| SMA: Bullish | Nov 15, 2022 | 3 years ago |
| SMA: Bearish | Sep 26, 2022 | 4 years ago |
| SMA: Bearish | Sep 19, 2022 | 4 years ago |
| SMA: Bullish | Aug 8, 2022 | 4 years ago |
| SMA: Bullish | Jul 11, 2022 | 4 years ago |
Key statistics
- Market cap
- 94.92M
- Enterprise value
- 92.26M
- Trailing P/E
- 0.00
- Forward P/E
- -2.68
- PEG ratio
- 0.00
- Price / sales
- 9.64
- Price / book
- 0.00
- EPS (TTM)
- -0.31
- Beta
- 1.38
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 9.85M
- Revenue growth
- 104.20%
- Free cash flow
- -1.87M
- Total cash
- 7.78M
- Total debt
- 5.12M
- Return on equity
- -334.02%
- Shares outstanding
- 272.84M
- Short % of float
- 4.23%
- 50-day average
- 0.328538
- 200-day average
- 0.289417
Analyst view
Consensus: hold
Hold
Price target (mean) 0.35
Next earnings
Aug 13, 2024
Expected Aug 13, 2024. Consensus EPS estimate -0.04.
Financials — quick view
ASXC Revenue — quarterly 2.21M
ASXC Net income — quarterly -25.75M
ASXC EPS — quarterly -0.09
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Aug 13, 2024 | Jun 1, 2024 | -0.05 | — | — | — |
| May 14, 2024 | Mar 1, 2024 | -0.05 | — | — | — |
| Mar 21, 2024 | Dec 1, 2023 | -0.05 | — | — | — |
| Nov 14, 2023 | Sep 1, 2023 | -0.07 | — | — | — |
| Aug 10, 2023 | Jun 1, 2023 | -0.08 | — | — | — |
| May 11, 2023 | Mar 1, 2023 | -0.07 | — | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 21, 2023 | Cantor Fitzgerald | reit | Overweight | Overweight |
| Aug 10, 2023 | HC Wainwright & Co. | reit | Buy | Buy |
| May 11, 2023 | HC Wainwright & Co. | reit | Buy | Buy |
| Mar 5, 2023 | HC Wainwright & Co. | main | — | Buy |
| Feb 21, 2023 | HC Wainwright & Co. | reit | — | Buy |
| Jan 9, 2023 | HC Wainwright & Co. | reit | — | Buy |
About Asensus Surgical, Inc.
Asensus Surgical, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery (MIS) in the United States, Europe, the Middle East, Africa, and Asia. It digitizes the interface between the surgeon and the patient to perform performance-guided surgery for surgeons to deliver outcomes to patients. The company's products include Senhance System, a multi-port robotic surgery system that allows up to four arms to control robotic instruments and a camera for laparoscopic procedures; instruments and other products, including 3mm diameter instruments, 3mm and 5mm hooks, and articulating instruments; and Senhance ultrasonic system, an advanced energy device to deliver controlled energy to ligate and divide tissue. The company was formerly known as TransEnterix, Inc. and changed its name to Asensus Surgical, Inc. in February 2021. Asensus Surgical, Inc. is headquartered in Durham, North Carolina.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Website
- asensus.com
News
- Asensus Surgical Announces Closing of Acquisition by KARL STORZ
- Asensus Surgical (ASXC) Reports Q2 Loss, Tops Revenue Estimates
- Asensus Surgical, Inc. (ASXC) Q2 2024 Earnings Call Transcript
- Asensus Surgical, Inc. Schedules Second Quarter Financial and Operating Results Conference Call for August 13, 2024
- Asensus Surgical 2024 Special Meeting of Stockholders Is Adjourned
- Independent Proxy Advisory Firm ISS Recommends Asensus Surgical Stockholders Vote “FOR” the Pending Merger with KARL STORZ
- Glass Lewis Recommends Asensus Surgical Stockholders Vote “FOR” Proposals Relating to Proposed Merger with KARL STORZ
- Asensus Surgical Receives FDA 510(k) Clearance for Senhance Surgical System in Urology
- Asensus Surgical Announces LKH-Universitätsklinikum Graz Hospital in Austria to Initiate Senhance Surgery Program
- Asensus Surgical (ASXC) Announces New Hospital Tie-Up on Senhance
Your note
Sign in to keep a note on ASXC — it syncs with the Stock Master app.
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Group Inc | 4.32% | 11,393,457 | 5.75M | Jun 29, 2023 |
| Blackrock Inc. | 1.40% | 3,699,987 | 1.87M | Jun 29, 2023 |
| Geode Capital Management, LLC | 0.80% | 2,108,122 | 1.06M | Jun 29, 2023 |
| Masters Capital Management, LLC | 0.76% | 2,000,000 | 1.01M | Jun 29, 2023 |
| Millennium Management Llc | 0.65% | 1,720,676 | 868.94K | Jun 29, 2023 |
| State Street Corporation | 0.36% | 952,929 | 481.23K | Jun 29, 2023 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 2.93% | 7,734,650 | 3.91M | Jun 29, 2023 |
| Vanguard Extended Market Index Fund | 1.21% | 3,205,099 | 1.62M | Jun 29, 2023 |
| Fidelity Extended Market Index Fund | 0.45% | 1,199,060 | 623.51K | May 30, 2023 |
| Mutual Fund Ser Tr-AlphaCentric Robotics & Automation Fund | 0.19% | 500,000 | 252.50K | Jun 29, 2023 |
| Fidelity Total Market Index Fund | 0.16% | 410,079 | 213.24K | May 30, 2023 |
| Fidelity Series Total Market Index Fund | 0.13% | 331,322 | 172.29K | May 30, 2023 |